Literature DB >> 28190250

Plasma carotenoids and the risk of premalignant breast disease in women aged 50 and younger: a nested case-control study.

Kevin Cohen1, Ying Liu1,2, Jingqin Luo1,2,3, Catherine M Appleton4, Graham A Colditz5,6.   

Abstract

PURPOSE: To examine the association of plasma carotenoids, micronutrients in fruits, and vegetables, with risk of premalignant breast disease (PBD) in younger women.
METHODS: Blood samples were collected at the Siteman Cancer Center between 2008 and 2012 from 3537 women aged 50 or younger with no history of cancer or PBD. The analysis included 147 participants diagnosed with benign breast disease or breast carcinoma in situ during a 27-month follow-up and 293 controls. Cases and controls were matched on age, race/ethnicity, and date of and fasting status at blood draw. Plasma carotenoids were quantified. We used logistic regression to calculate odds ratios (ORs) and 95% confidence intervals (CIs) and linear regression to assess racial differences in plasma carotenoids.
RESULTS: The risk reduction between the highest and lowest tertiles varied by carotenoid, with β-cryptoxanthin having the greatest reduction (OR 0.62; 95% CI, 0.62-1.09; P trend = 0.056) and total carotenoids the least (OR 0.83; 95% CI, 0.48-1.44; P trend = 0.12). We observed an inverse association between plasma carotenoids and risk of PBD in obese women (BMI ≥ 30 kg/m2; 61 cases and 115 controls) but not lean women (BMI < 25 kg/m2; 54 cases and 79 controls), although the interaction was not statistically significant. Compared to white women, black women had lower levels of α and β-carotene and higher levels of β-cryptoxanthin and lutein/zeaxanthin.
CONCLUSIONS: We observed suggestive inverse associations between plasma carotenoids and risk of PBD in younger women, consistent with inverse associations reported for invasive breast cancer. Carotenoids may play a role early in breast cancer development.

Entities:  

Keywords:  African American; Benign breast disease; Breast cancer; Carotenoids; Prevention

Mesh:

Substances:

Year:  2017        PMID: 28190250      PMCID: PMC5341742          DOI: 10.1007/s10549-017-4152-5

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  42 in total

1.  An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions.

Authors:  S R Wellings; H M Jensen; R G Marcum
Journal:  J Natl Cancer Inst       Date:  1975-08       Impact factor: 13.506

2.  Diet and histologic types of benign breast disease defined by subsequent risk of breast cancer.

Authors:  T G Hislop; P R Band; M Deschamps; V Ng; A J Coldman; A J Worth; T Labo
Journal:  Am J Epidemiol       Date:  1990-02       Impact factor: 4.897

3.  Lycopene and other carotenoids inhibit estrogenic activity of 17beta-estradiol and genistein in cancer cells.

Authors:  Keren Hirsch; Andrea Atzmon; Michael Danilenko; Joseph Levy; Yoav Sharoni
Journal:  Breast Cancer Res Treat       Date:  2006-10-19       Impact factor: 4.872

4.  Dietary and reproductive factors associated with benign breast disease in Mexican women.

Authors:  Marcia Galván-Portillo; Luisa Torres-Sánchez; Lizbeth López-Carrillo
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

Review 5.  Dietary compared with blood concentrations of carotenoids and breast cancer risk: a systematic review and meta-analysis of prospective studies.

Authors:  Dagfinn Aune; Doris S M Chan; Ana Rita Vieira; Deborah A Navarro Rosenblatt; Rui Vieira; Darren C Greenwood; Teresa Norat
Journal:  Am J Clin Nutr       Date:  2012-07-03       Impact factor: 7.045

6.  Plasma carotenoids and breast cancer risk in the Cancer Prevention Study II Nutrition Cohort.

Authors:  Ying Wang; Susan M Gapstur; Mia M Gaudet; Jeremy D Furtado; Hannia Campos; Marjorie L McCullough
Journal:  Cancer Causes Control       Date:  2015-06-17       Impact factor: 2.506

7.  Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies.

Authors:  A Heather Eliassen; Sara J Hendrickson; Louise A Brinton; Julie E Buring; Hannia Campos; Qi Dai; Joanne F Dorgan; Adrian A Franke; Yu-tang Gao; Marc T Goodman; Göran Hallmans; Kathy J Helzlsouer; Judy Hoffman-Bolton; Kerstin Hultén; Howard D Sesso; Anne L Sowell; Rulla M Tamimi; Paolo Toniolo; Lynne R Wilkens; Anna Winkvist; Anne Zeleniuch-Jacquotte; Wei Zheng; Susan E Hankinson
Journal:  J Natl Cancer Inst       Date:  2012-12-06       Impact factor: 13.506

8.  Risk factors for breast cancer in women with proliferative breast disease.

Authors:  W D Dupont; D L Page
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

9.  Recent trends in breast cancer among younger women in the United States.

Authors:  Louise A Brinton; Mark E Sherman; J Daniel Carreon; William F Anderson
Journal:  J Natl Cancer Inst       Date:  2008-11-11       Impact factor: 13.506

10.  The role of diet in the development of breast cancer: a case-control study of patients with breast cancer, benign epithelial hyperplasia and fibrocystic disease of the breast.

Authors:  D M Ingram; E Nottage; T Roberts
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

View more
  2 in total

1.  Effects of β-Cryptoxanthin on Improvement in Osteoporosis Risk: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Sun Jo Kim; Nguyen Hoang Anh; Nguyen Co Diem; Seongoh Park; Young Hyun Cho; Nguyen Phuoc Long; In Guk Hwang; Johan Lim; Sung Won Kwon
Journal:  Foods       Date:  2021-02-02

2.  Joanne Knight Breast Health Cohort at Siteman Cancer Center.

Authors:  Graham A Colditz; Debbie L Bennett; Jennifer Tappenden; Courtney Beers; Nicole Ackermann; Ningying Wu; Jingqin Luo; Sarah Humble; Erin Linnenbringer; Kia Davis; Shu Jiang; Adetunji T Toriola
Journal:  Cancer Causes Control       Date:  2022-01-21       Impact factor: 2.506

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.